Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Almuth F Kessler

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Acta Neuropathologica|October 9, 2025
Tumor-associated macrophages in meningiomas: a novel biomarker for poor survival outperforming the benefits of T cellsCatharina Lotsch, Rolf Warta, Fang Liu, et al.
Oncotarget|February 20, 2016
Transcriptomic analysis of aggressive meningiomas identifies PTTG1 and LEPR as prognostic biomarkers independent of WHO gradeMelissa Schmidt, Andreas Mock, Christine Jungk, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 23, 2019
Cytotoxic T Cells and their Activation Status are Independent Prognostic Markers in MeningiomasCarmen Rapp, Steffen Dettling, Fang Liu, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 31, 2025
Distress screening in patients with high-grade glioma: diagnostic accuracy in relation to a structured clinical interview in a multicenter cluster-randomized controlled trialRobert Kuchen, Susanne Singer, Melanie Schranz, et al.
Journal of the National Cancer Institute|August 14, 2013
Effects of the selective MPS1 inhibitor MPS1-IN-3 on glioblastoma sensitivity to antimitotic drugsBakhos A Tannous, Mariam Kerami, Petra M Van der Stoop, et al.
Journal of Neuro-Oncology|September 10, 2025
Physician-led versus questionnaire-based psychosocial screening in adults with high-grade glioma: a cluster-randomized controlled trial (GLIOPT)Mirjam Renovanz, Melina Hippler, Robert Kuchen, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Acta Neuropathologica|October 9, 2025
Tumor-associated macrophages in meningiomas: a novel biomarker for poor survival outperforming the benefits of T cellsCatharina Lotsch, Rolf Warta, Fang Liu, et al.
Oncotarget|February 20, 2016
Transcriptomic analysis of aggressive meningiomas identifies PTTG1 and LEPR as prognostic biomarkers independent of WHO gradeMelissa Schmidt, Andreas Mock, Christine Jungk, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 23, 2019
Cytotoxic T Cells and their Activation Status are Independent Prognostic Markers in MeningiomasCarmen Rapp, Steffen Dettling, Fang Liu, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 31, 2025
Distress screening in patients with high-grade glioma: diagnostic accuracy in relation to a structured clinical interview in a multicenter cluster-randomized controlled trialRobert Kuchen, Susanne Singer, Melanie Schranz, et al.
Journal of the National Cancer Institute|August 14, 2013
Effects of the selective MPS1 inhibitor MPS1-IN-3 on glioblastoma sensitivity to antimitotic drugsBakhos A Tannous, Mariam Kerami, Petra M Van der Stoop, et al.
Journal of Neuro-Oncology|September 10, 2025
Physician-led versus questionnaire-based psychosocial screening in adults with high-grade glioma: a cluster-randomized controlled trial (GLIOPT)Mirjam Renovanz, Melina Hippler, Robert Kuchen, et al.
Pageof 4